Above: The Federal Trade Commission building in Washington, DC
© ISTOCK.COM, ROMAN BABAKIN
The Federal Trade Commission earlier this month (October 12) filed a complaint in California district court against two stem cell clinics and the physician who runs them, claiming that the companies made unsupported claims about the effectiveness of their therapies. Today, the companies and the FTC have settled the charges, the agency announced in a press release. In the future, the companies will be prohibited from false advertising about their medical services, according to the proposed order (filed October 16) documenting this settlement. They will also pay a penalty.
This is not the first time that stem cell clinics, of which there are hundreds in the US, have been accused of misleading and unsafe business practices, as STAT notes, but this is the first time that the FTC has taken action against them.
The two companies, Regenerative Medical ...
